Skip to content

A prospective emulated target clinical trial of Pingwei Jianzhong Jiedu decoction granules and decoction in the treatment of gastric precancerous lesions

A prospective emulated target clinical trial of Pingwei Jianzhong Jiedu decoction granules and decoction in the treatment of gastric precancerous lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000199
Enrollment
Unknown
Registered
2024-08-09
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric precancerous lesions

Interventions

usual care group:no intervention
Pingwei Jianzhong Jiedu decoction group:no intervention
Pingwei Jianzhong Jiedu granula group:no intervention

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Which conforms to the diagnostic criteria of patients' informed consent and voluntary researchers (diagnostic criteria: the diagnosis of gastric mucosa precancerous lesions with the Chinese medical association in 2017 chronic gastritis consensus opinion of the People's Republic of China, and, in combination with endoscopic diagnosis and pathology diagnosis and pathological diagnosis for the final diagnosis, the chronic atrophic gastritis with intestinal metaplasia or hyperplasia); (2) patients aged 18 to 70 years old.

Exclusion criteria

Exclusion criteria: 1) Gastric cancer; 2) with other digestive diseases; 3) combined with malignant tumors; 4) Complicated with serious heart, lung, liver, kidney and other important organ diseases; 5) severe brain disease or mental illness affecting the patient's ability to report; 6) pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Clinical symptom scores;

Secondary

MeasureTime frame
Gastroscopic pathological indexes were scored;

Countries

China

Contacts

Public ContactJiamin Xu

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

jiaminxu@gzucm.edu.cn15626218487

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026